J&J | L'Utile Operativo



Operating Profit Cambiamento Data
AbbVie USD 3.73B 5.22B 2025-03
Abbott USD 1.66B 253M 2025-03
Amgen USD 2.31B 182M 2024-12
AstraZeneca USD 3.67B 1.64B 2025-03
Baxter International USD -435000000 590M 2024-12
Bayer EUR 3.53B 7.35B 2024-12
Becton, Dickinson and Co. USD 453M 195M 2024-12
Biogen USD 441.4M 24.4M 2024-12
Boston Scientific USD 921M 246M 2025-03
Bristol-Myers Squibb USD 3.41B 2.62B 2025-03
CONMED USD 15.96M 36.54M 2025-03
Cooper Companies USD 182M 16.4M 2025-01
Dexcom USD 188.9M 36.9M 2024-12
Edwards Lifesciences USD 394.8M 82.2M 2025-03
Eli Lilly USD 5.41B 259.6M 2025-03
Gilead Sciences USD 2.24B 215M 2025-03
GlaxoSmithKline GBP 2.22B 1.52B 2025-03
Globus Medical USD 60.27M 12.18M 2024-12
Hologic USD 229.8M 200K 2024-12
Indivior 66M 226M 2025-03
Insulet USD 109.3M 21.2M 2024-12
Integra LifeSciences USD 35.23M 43.36M 2024-12
Intuitive Surgical USD 578.1M 156.8M 2025-03
J&J USD 13.63B 9.74B 2025-03
Medtronic USD 1.65B 51M 2025-01
Merck USD 5.87B 1.57B 2025-03
Merit Medical Systems USD 41.03M 4.47M 2025-03
Novartis USD 2.28B 1.34B 2024-12
Pfizer USD 3.67B 4.08B 2025-03
Regeneron Pharmaceuticals USD 591.7M 398.5M 2025-03
Roche Holding CHF 4.39B 1.04B 2024-12
Sanofi EUR 2.28B 1.42B 2025-03
Stryker USD 581M 504M 2024-12
Tandem Diabetes Care USD -120878000 120.3M 2025-03
Teva Pharmaceutical Industries USD 455M 506M 2024-12
Vertex Pharmaceuticals USD 1.03B 90.3M 2024-12
Zimmer Biomet Holdings USD 389M 109.5M 2024-12
Zoetis USD 732M 142M 2024-12



J&J L'Utile Operativo - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.